EXAI - Exscientia Shares Surge On AI Collaboration: The Details | Benzinga
Exscientia Plc (NASDAQ: EXAI) shares are trading higher Wednesday after the company announced an AI drug discovery collaboration with Merck KGaA, Darmstadt, Germany.
What Happened: Exscientia announced a new multi-year collaboration with Merck KGaA focused on discovering small molecule oncology, neuroinflammation and immunology drug candidates. Exscientia will pair its AI capabilities with Merck KGaA's oncology and neuroinflammation expertise.
The companies have identified three targets to initially focus on and could name additional ...